Search company, investor...

Founded Year

2018

Stage

Seed | Alive

About Daisy

Daisy is a worldwide AI platform based on blockchain technology for deep learning. The company is creating an AI platform where developers from all over the world can collaborate together in the creation of AI. The Daisy platform enables the creation of highly-accurate AI by integrating the resources of varying developers from all over the world and compensating them for their contributions.

Headquarters Location

1-chōme-3-12 Sotokanda Chiyoda-ku

Tokyo, 101-0021,

Japan

Loading...

Loading...

Expert Collections containing Daisy

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Daisy is included in 2 Expert Collections, including Blockchain.

B

Blockchain

6,949 items

Companies in this collection build, apply, and analyze blockchain and cryptocurrency technologies for business or consumer use cases. Categories include blockchain infrastructure and development, crypto & DeFi, Web3, NFTs, gaming, supply chain, enterprise blockchain, and more.

A

Artificial Intelligence

10,958 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.

Daisy Patents

Daisy has filed 6 patents.

The 3 most popular patent topics include:

  • body modification
  • cosmetics
  • lithics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/5/2019

11/7/2023

Grant

Application Date

7/5/2019

Grant Date

11/7/2023

Title

Related Topics

Status

Grant

Latest Daisy News

Episode 2 – Founder perspectives with Daisy Isiaho

Oct 18, 2023

The importance of accelerator programs for African startups Key benefits Daisy gained from VC4A and other accelerators: mentorship, peer learning, funding access Unique aspects of the VC4A Venture Showcase – Women Founder Edition Tips for entrepreneurs considering applying to accelerator programs About our guest: Daisy Isiaho Daisy is the co-founder and Chief Product Officer of Zuri Health, a health tech company providing universally accessible and convenient healthcare experience. Daisy excels in strategic thinking, business development, and tech leadership. She’s also a Bayer Foundation Women Empowerment Award 2022 winner and top 25 Women in Digital 2022 honoree. About the VC4A Venture Showcase: The VC4A Venture Showcase is an exclusive program of choice for entrepreneurs looking to raise their Seed and Series A rounds. Since 2017, it is one of the leading accelerator programs in Africa and Latam. The Showcase brings together the most active investors, experienced mentors and the continent’s best founders. Visit the VC4A Venture Showcase website to learn more. About Entrepreneurs Talk Africa: The Entrepreneurs Talk Africa Podcast positions itself as the platform where the African entrepreneurs can find and share the inspirations, resources and networks to thrive in their entrepreneurial journeys through relatable stories and insights from fellow leading African entrepreneurs. Through interviews with successful entrepreneurs, masterclasses and theme-specific mini series, we empower the African entrepreneurs to take a leap forward. We also aim to provide a growing audience for Entrepreneur support organisations to reach, educate and engage while ensuring we provide value for both.

Daisy Frequently Asked Questions (FAQ)

  • When was Daisy founded?

    Daisy was founded in 2018.

  • Where is Daisy's headquarters?

    Daisy's headquarters is located at 1-chōme-3-12 Sotokanda, Tokyo.

  • What is Daisy's latest funding round?

    Daisy's latest funding round is Seed.

  • Who are the investors of Daisy?

    Investors of Daisy include Remixpoint.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.